Development of an effective method for dendritic cell immunotherapy of mouse melanoma

Immunology and Microbiology

• Dendritic Cell 100%
• Tumor Antigen 75%
• Mouse 75%
• Dendritic Cell Immunotherapy 50%
• Immunotherapy 25%
• Survival Rate 25%
• Tumor Volume 25%
• Molecule 12%
• T Cell Proliferation 12%
• Monospecific Antibody 12%
• Secretion (Process) 12%
• Bone Marrow Derived Dendritic Cell 12%
• Surface Property 12%
• CD86 12%
• MHC Class II 12%
• CD80 12%
• Development 12%
• Cells 12%
• Reduction (Chemistry) 12%

Biochemistry, Genetics and Molecular Biology

• Dendritic Cell 100%
• Tumor Antigen 75%
• Mouse 75%
• Survival Rate 25%
• Tumor Volume 25%
• Tumor Necrosis Factor 25%
• Clinical Trial 25%
• Molecule 12%
• Secretion (Process) 12%
• Surface Property 12%
• Reduction (Chemistry) 12%
• CD80 12%
• CD86 12%
• Development 12%
• MHC Class II 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Immunotherapy 75%
• Tumor Antigen 75%
• Mouse 75%
• Melanoma 62%
• Cytokine 25%
• Neoplasm 25%
• Survival Rate 25%
• Antibody 12%
• Malignant Neoplasm 12%
• Absence 12%
• Cell Proliferation 12%